Michael A. Koldobskiy

Michael A. Koldobskiy

Pediatric Hematology Oncology | Pediatrics

1800 Orleans Street, Bloomberg 11N
Bloomberg 11N
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

Journal: bioRxiv : the preprint server for biology

Published: June 29, 2026

Overcoming immunotherapy barriers in pediatric brain tumors: epigenetic strategies.

Overcoming immunotherapy barriers in pediatric brain tumors: epigenetic strategies.

Journal: Frontiers in oncology

Published: April 15, 2026

Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.

Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.

Journal: Neuro-oncology practice

Published: December 29, 2025

DNA Methylation Stochasticity Is Linked to Transcriptional Variability and Convergent Epigenetic Disruption across Genetic Subtypes of Acute Myeloid Leukemia.

DNA Methylation Stochasticity Is Linked to Transcriptional Variability and Convergent Epigenetic Disruption across Genetic Subtypes of Acute Myeloid Leukemia.

Journal: Cancer research

Published: December 22, 2025

CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1.

CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1.

Journal: Molecular cancer

Published: October 01, 2025

Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT.

Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT.

Journal: Acta neuropathologica communications

Published: August 25, 2025

Convergence of aging- and rejuvenation-related epigenetic alterations on PRC2 targets.

Convergence of aging- and rejuvenation-related epigenetic alterations on PRC2 targets.

Journal: Molecular systems biology

Published: February 25, 2025

DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency.

DNMT3AR882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell Frequency.

Journal: bioRxiv : the preprint server for biology

Published: November 18, 2024

DNA methylation stochasticity is linked to transcriptional variability and identifies convergent epigenetic disruption across genetically-defined subtypes of AML.

DNA methylation stochasticity is linked to transcriptional variability and identifies convergent epigenetic disruption across genetically-defined subtypes of AML.

Journal: bioRxiv : the preprint server for biology

Published: November 18, 2024

Progress Toward Epigenetic Targeted Therapies for Childhood Cancer.

Progress Toward Epigenetic Targeted Therapies for Childhood Cancer.

Journal: Cancers

Published: November 08, 2024

DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency.

DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML but Is Associated with Increased Leukemia Stem Cell Frequency.

Journal: Cancer discovery

Published: November 01, 2024

DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically.

DNA methylation landscapes in DIPG reveal methylome variability that can be modified pharmacologically.

Journal: Neuro-oncology advances

Published: March 12, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026